Bloomington Hospital
Bloomington, Indiana 47403
0 studies enrolling now · 35 studies all time
What they study most
Anal Cancer, Anemia, Atrial Fibrillation, Bladder Cancer, Brain and Central Nervous System Tumors, Breast Cancer, Cachexia, Carcinoma of Unknown Primary, Cervical Cancer, Chronic Myeloproliferative Disorders, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ
Studies at this site
- A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
- Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer — Completed
- Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy — Completed
- Longitudinal Surveillance Study of the 4-SITE Lead/Header System — Completed
- Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer — Completed
- Melatonin and Radiation Therapy in Treating Patients With Brain Metastases — Completed
- Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer — Completed
- Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme — Completed
- Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme — Completed
- External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer — Completed
- Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum — Completed
- Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer — Completed
- Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor — Completed
- Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord — Completed
- Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer — Completed
- Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer — Completed
- Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme — Completed
- Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer — Completed
- Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer — Completed
- Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer — Completed
- Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma — Withdrawn before enrolling
- Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer — Completed
- Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer — Completed
- Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer — Status unconfirmed
- Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically — Status unconfirmed
- Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer — Completed
- Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery — Completed
- Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma — Withdrawn before enrolling
- Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma — Completed
- Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma — Completed
- S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer — Completed
- High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma — Completed
- Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer — Completed
- Tumor Cell Vaccine in Treating Patients With Advanced Cancer — Completed
- Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer — Completed